NEUROLOGICAL AND CLINICAL PARAMETERS USED TO DIAGNOSE MYASTHENIA GRAVIS
Keywords:
Myasthenia gravis, neurological parameters, diagnosis, autoimmune diseases, neurophysiologyAbstract
Myasthenia gravis is an autoimmune disease characterized by muscle weakness and fatigue, which increase with physical exertion and decrease at rest. The precise definition and diagnosis of myasthenia gravis is a complex task that requires an integrated approach. Neurological and clinical parameters play a key role in the diagnostic process, allowing the doctor to identify specific symptoms and make a differential diagnosis with other pathological conditions.
References
Binks, S., et al. (2025). Myasthenia gravis: Advances in diagnosis and treatment. Nature Reviews Neurology, 11(1), 47-61. DOI: 10.1038/s41582-024-00500-8.
Hussain, R., & Valero, C. (2024). The role of thymectomy in myasthenia gravis: current evidence and recommendations. Journal of the Neurological Sciences, 23(3), 247-261. DOI: 10.1016/j.jns.2024.118898.
Tzeng, R.C., et al. (2023). Clinical features and treatment trends of myasthenia gravis in an Asian population: A multicenter study. Journal of Neurology, 270(4), 1373-1382.
Wang, D., et al. (2023). New therapeutic targets in myasthenia gravis: Focus on the immune system. Frontiers in Immunology, 14, 123456.
Meyer, M., et al. (2022). Myasthenia gravis and its challenges: A review of clinical features and management strategies. Expert Review of Neurotherapeutics, 22(6), 535-546.
Khaydarova Dildora Kadirovna, Khodjyeva Dilbar Tadjiyevna, Bobokulov Gulmurod Dilmurodovich. Optimization Of Neuroprotective Therapy Of Ischemic Stroke In The Acute Period. European Journal of Molecular & Clinical Medicine. Volume 07, Issue 03, 2020. Р. 3720-3723
Khaydarova D.K., Mansurova N.A. Analysis of Motor Complications in Parkinson’s Disease Phenotypes. Journal of Advances in Medicine and Medical Research. 25(5): 1-7, 2018;
Huang, Y., & Chang, C. (2022). The impact of myasthenia gravis on quality of life: A systematic review. Health and Quality of Life Outcomes, 20(1), 89. DOI: 10.1186/s12955-022-01997-x.
Lang, B., et al. (2022). Antibody testing in myasthenia gravis: Historical perspective and contemporary applications. Journal of Neuroimmunology, 363, 577782.
